摘要：
2025年2月21日, 北京大学药学院天然药物及仿生药物全国重点实验室谢海燕团队与合作者在Science Advances杂志刊登了通过诱导三级淋巴结从头生成提高肿瘤免疫治疗效果的最新研究成果“Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis”(纳米囊泡激活瘤内抗原呈递细胞诱发三级淋巴样结构从头生成) 。
Supporting:
北京大学药学院天然药物及仿生药物全国重点实验室. 北大谢海燕/北理聂伟东提出通过激活瘤内抗原提呈细胞诱导三级淋巴结从头生成新策略[J]. 中国药学(英文版), 2025, 34(3): 300-301.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research teams of Prof. Haiyan Xie and Prof. Weidong Nie proposed a new strategy to induce the concurrent tertiary lymphoid structure de novo neogenesis by activating intratumoral antigen-presenting cells[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(3): 300-301.
>
>